Triamterene and Hydrochlorothiazide (NCS HealthCare of KY, Inc dba Vangard Labs)
Welcome to the PulseAid listing for the Triamterene and Hydrochlorothiazide drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | NCS HealthCare of KY, Inc dba Vangard Labs |
| NON-PROPRIETARY NAME: | triamterene and hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-05-04 |
| END MARKETING DATE: | 0000-00-00 |
Triamterene and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Triamterene and Hydrochlorothiazide from NCS HealthCare of KY, Inc dba Vangard Labs |
| LABELER NAME: | NCS HealthCare of KY, Inc dba Vangard Labs |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 37.5(mg/1; mg/1) |
| START MARKETING DATE: | 2011-05-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0615-1333_194a19cf-d20f-43f0-b279-e23b8e23f540 |
| PRODUCT NDC: | 0615-1333 |
| APPLICATION NUMBER: | ANDA074701 |
Other HYDROCHLOROTHIAZIDE; TRIAMTERENE Pharmaceutical Manufacturers / Labelers:
